Zusammenfassung

• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -59,13 +59,19 @@
59	59	(% class="Bullet" %)-(%%) Pyoderma gangraenosum
60	60
61	61	(% class="Eintrag-2" %)
62		-(% class="Feature" %)TF:(%%) Infekte
	62	+(% class="Feature" %)TF:(%%) (% class="Bullet" %)-(%%) Infekte
63	63
64	64	(% class="Ebene-2" %)
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
	67	+(% class="Ebene-1" %)
	68	+(% class="Bullet" %)-(%%) Dupilumab
	69	+
	70	+(% class="Ebene-2" %)
	71	+(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2023 Nov 27. [[http:~~/~~/doi.org/10.1111/ajd.14190>>url:http://doi.org/10.1111/ajd.14190]]
	72	+
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
	74	+(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) AGEP
69	69
70	70	(% class="Ebene-1" %)
71	71	(% class="Bullet" %)-(%%) Dermatitis herpetiformis
...	...	@@ -79,11 +79,14 @@
79	79	(% class="Ebene-1" %)
80	80	(% class="Bullet" %)-(%%) Pemphigus foliaceus
81	81
82		-(% class="Eintrag-2" %)
	88	+(% class="Ebene-1" %)
	89	+(% class="Bullet" %)-(%%) anuläre Psoriasis pustulosa
83	83
	91	+(% class="Ebene-2" %)
	92	+(% class="Feature" %)Bsp:(%%) annular pustular psoriasis
84	84
85		-(% class="Ebene-1" %)
86		-(% class="Bullet" %)-(%%) Psoriasis pustulosa
	94	+(% class="Ebene-2" %)
	95	+(% class="Feature" %)Lit:(%%) Pediatr Dermatol. 2023 Jan 31. [[http:~~/~~/doi.org/10.1111/pde.15251>>url:http://doi.org/10.1111/pde.15251]]
87	87
88	88	(% class="Ebene-1" %)
89	89	(% class="Bullet" %)-(%%) Tinea incognito
...	...	@@ -125,7 +125,7 @@
125	125	(% class="Feature" %)Lit:(%%) J Dermatol 2000; 27: 669-72
126	126
127	127	(% class="Ebene-3" %)
128		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	137	+(% class="Feature" %)PT:(%%) CR
129	129
130	130	(% class="Ebene-3" %)
131	131	(% class="Feature" %)Altn:(%%) Maxacalcitol
...	...	@@ -134,7 +134,7 @@
134	134	(% class="Feature" %)Lit:(%%) Clin Exp Dermatol. 2015 May 19. [[http:~~/~~/doi.org/10.1111/ced.12680>>url:http://doi.org/10.1111/ced.12680]]
135	135
136	136	(% class="Ebene-5" %)
137		-(% class="Feature" %)Lit:(%%) (% class="Abbreviation" %)CR(%%)
	146	+(% class="Feature" %)Lit:(%%) CR
138	138
139	139	(% class="Ebene-2" %)
140	140	(% class="Bullet" %)-(%%) Dapson Gel
...	...	@@ -149,7 +149,7 @@
149	149	(% class="Bullet" %)-(%%) Dapson
150	150
151	151	(% class="Ebene-3" %)
152		-(% class="Feature" %)Bed:(%%) (% class="Abbreviation" %)GS(%%)
	161	+(% class="Feature" %)Bed:(%%) GS
153	153
154	154	(% class="Ebene-3" %)
155	155	(% class="Feature" %)Dos:(%%) 100-150 mg/Tag
...	...	@@ -188,8 +188,11 @@
188	188	(% class="Bullet" %)-(%%) Apremilast
189	189
190	190	(% class="Ebene-3" %)
191		-(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
	200	+(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
192	192
	202	+(% class="Ebene-3" %)
	203	+(% class="Bullet" %)-(%%) Australas J Dermatol. 2023 Aug;64(3):e310-e312. [[http:~~/~~/doi.org/10.1111/ajd.14073>>url:http://doi.org/10.1111/ajd.14073]]
	204	+
193	193	(% class="Ebene-2" %)
194	194	(% class="Bullet" %)-(%%) Anti-TNF-alpha
195	195
...	...	@@ -206,7 +206,7 @@
206	206	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
207	207
208	208	(% class="Ebene-5" %)
209		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	221	+(% class="Feature" %)PT:(%%) CR
210	210
211	211	(% class="Ebene-2" %)
212	212	(% class="Bullet" %)-(%%) Guselkumab